Publications by authors named "R Lopez-Reyes"
Article Synopsis
- The AIR trial investigates the effects of supplemental oxygen therapy in patients with intermediate-risk pulmonary embolism (PE) who have normal oxygen levels at baseline.
- It is a multicenter, randomized trial involving 90 patients, aiming to see if oxygen reduces strain on the right ventricle (RV) over 48 hours compared to those receiving ambient air.
- This research hopes to enhance treatment strategies for acute PE, especially for those patients who currently show no signs of low oxygen levels.
In patients with lung cancer and venous thromboembolism (VTE), the influence of cancer histology on outcome has not been consistently evaluated. We used the RIETE registry (Registro Informatizado Enfermedad TromboEmbólica) to compare the clinical characteristics and outcomes during anticoagulation in patients with lung cancer and VTE, according to the histology of lung cancer. As of April 2022, there were 482 patients with lung cancer and VTE: adenocarcinoma 293 (61%), squamous 98 (20%), small-cell 44 (9.
View Article and Find Full Text PDFRobust evidence on the optimal management of splanchnic vein thrombosis (SVT) is lacking. We conducted an individual-patient meta-analysis to evaluate the effectiveness and safety of anticoagulation for SVT. Medline, Embase, and clincaltrials.
View Article and Find Full Text PDFBackground: A recent trial showed that management driven by prognostic assessment was effective in reducing the length of stay (LOS) for acute stable pulmonary embolism (PE). The efficacy and safety of this strategy in each subgroup of risk stratification remains unknown.
Methods: We conducted a analysis of the randomized IPEP study to evaluate the effect of a management strategy guided by early use of a prognostic pathway in the low- and intermediate-high risk subgroups defined by the European Society of Cardiology (ESC) model.